EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arvay, A.
Right arrow Articles by Lengyel, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arvay, A.
Right arrow Articles by Lengyel, M.

European Journal of Cardio-Thoracic Surgery, Vol 2, 340-346, Copyright © 1988 by European Association for Cardio-thoracic Surgery


ARTICLES

Incidence and risk factors of prosthetic valve endocarditis

A Arvay and M Lengyel
Hungarian Institute of Cardiology, Budapest.

To study the incidence and risk factors of prosthetic valve endocarditis (PVE) we followed 99.5% of 912 patients who had valve replacements from 1 January 1981 to 31 December 1985 for 1-6 (mean 3) years. PVE occurred in 27 patients (2.96% or 0.98% per patient-year). The incidence of PVE in the aortic position (3.9%) was significantly higher than in the mitral position (1.5%): chi-square = 6.1, P less than 0.025. PVE developed in 19 of 329 patients with bioprostheses (5.8%), and in 8 of 583 patients with mechanical valves (1.4%): chi- square = 14.48, P less than 0.005). Actuarially at 5-year follow-up, 90.7% +/- 2.16% of the bioprosthetic group and 98.4% +/- 0.56% of the mechanical valve group was free of PVE (P less than 0.001). Antecedent endocarditis increased both the incidence and relative risk of PVE 7- fold compared to patients without antecedent endocarditis (chi-square = 32.0, P less than 0.0001). Bioprosthetic valve replacement in infective endocarditis increased the risk of PVE 12-fold compared to valve replacement by mechanical prostheses. In conclusion: in the order of importance, antecedent endocarditis, bioprostheses and aortic position are risk factors in the development of PVE. Bioprostheses implanted in patients with antecedent endocarditis further enhance the risk of PVE.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. C. Farinas, A. Perez-Vazquez, C. Farinas-Alvarez, J. D. Garcia-Palomo, J. M. Bernal, J. M. Revuelta, and J. Gonzalez-Macias
Risk Factors of Prosthetic Valve Endocarditis: A Case-Control Study
Ann. Thorac. Surg., April 1, 2006; 81(4): 1284 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Siniawski, O. Grauhan, M. Hofmann, M. Pasic, Y. Weng, C. Yankah, H. Lehmkuhl, and R. Hetzer
Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 434 - 440.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
F. Filsoufi and D. H. Adams
Surgical Treatment of Mitral Valve Endocarditis
Card. Surg. Adult, January 1, 2003; 2(2003): 987 - 997.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. R. Clarke
Presidential address: Value, viability, and valves
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 1 - 6.
[Full Text] [PDF]


Home page
NEJMHome page
E. Mylonakis and S. B. Calderwood
Infective Endocarditis in Adults
N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. M. Safi, T. Kwan, E. Afflu, A. Al Kamme, and L. Salciccioli
Paravalvular Regurgitation: A Rare Complication Following Valve Replacement Surgery
Angiology, June 1, 2000; 51(6): 479 - 487.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Alexiou, S. M. Langley, H. Stafford, J. A. Lowes, S. A. Livesey, and J. L. Monro
Surgery for active culture-positive endocarditis: determinants of early and late outcome
Ann. Thorac. Surg., May 1, 2000; 69(5): 1448 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. L. Grover, D. J. Cohen, C. Oprian, W. G. Henderson, G. Sethi, K. E. Hammermeister, and Participants in the Department of Veterans Affairs
Determinants of the occurrence of and survival from prosthetic valve endocarditisExperience of the Veterans Affairs Cooperative Study on Valvular Heart Disease
J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 207 - 214.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.